The U.S. is on the verge of the largest shift the patent system has seen in decades as President Barack Obama prepares to sign a bill that will transform the process from a first-to-invent system to a first-to-file system.
The "America Invents Act," six years in the making, passed the Senate last week in a sweeping 89 to 9 vote accepting the bill, having won House approval in a similarly large landslide in March.
David Dykeman started practicing patent law more than 15 years ago and has since amassed a wealth of experience in in medical devices, information technology, nanotechnology and life sciences.
His areas of expertise include intellectual property, patent prosecution, copyrights and licensing.
As well as his role as attorney and shareholder at the Boston office of GreenbergTraurig and sitting on the board of the Massachusetts Medical Device Industry Council (Mass MEDIC), he has written a slew of articles, penned two books on intellectual property laws and spoken at dozens of conferences and seminars about med-tech and patent law.
Click here to hear more about his background and areas of concentration.
Or pick from other segments of the interview:
- Main page: Patent attorney David Dykeman breaks down the America Invents Act
- Background on the America Invents Act
- Winners and losers under patent reform
- Pitfalls and windfalls under patent reform
- “File early, file often”
- The post-grant challenge period
- Patent trolls and infringement lawsuits under patent reform
- The Supreme Court’s hand in shaping patent law
- In-house initiatives at the U.S. Patent & Trademark Office
- Meet David Dykeman